New Products

Recombinant Pfs230D1, Pfs48/45, Pfs25, and CSP Antigens with Matched Monoclonal Antibodies for Malaria Transmission-Blocking Vaccine Research and Binding Assay Development.

One-Stop Antigen Panel for Six Emerging and Arboviral Pathogens (Oropouche, VEEV, CHIKV, YFV, SFTSV, CCHFV) Supporting Arbovirus Research, Serology Assay Development, and Vaccine Research.

Site-Specifically Biotinylated Avi-Tag Antigens with Defined Single-Site Labeling, Robust Batch-to-Batch Consistency, and Plug-and-Play Streptavidin Compatibility for Immunoassay and Biosensor Research.

Blood-based biomarkers are reshaping the diagnosis of Alzheimer's disease (AD) and related neurodegenerative disorders.

Environmental toxicology and aquatic risk assessment increasingly rely on biomarker-based evidence to understand how chemical exposure translates into biological effects.

Yeast-Expressed High-Risk HPV L1 VLPs for Serological Assay Development, Antibody Screening, and Vaccine-Related Research.

High-Quality Multi-Species Native Hemoglobin Reagents for Veterinary Diagnostics, Immunoassay Development, and Comparative Biomedical Research Multi-Species Native Hemoglobin Reagents.

Advanced Recombinant Platforms for Antimicrobial Resistance Research, Diagnostics, and Drug Discovery

High-Performance Antibodies for Monkey Immunophenotyping and Preclinical Drug Development

Infectious diseases are caused by pathogenic microorganisms such as viruses, bacteria, parasites, fungi, and prions. These pathogens invade the human body, multiply within host tissues, and may disrupt normal physiological functions, leading to a wide range of clinical symptoms.

Biological products are pharmaceuticals derived from microorganisms, cells, animal tissues, and fluids through biotechnological processes for the prevention, treatment, and diagnosis of human diseases.

Infectious diseases are a major cause of morbidity and mortality in horses and also generate substantial economic and societal impacts.

The West Nile virus (WNV) Non-Structural Protein 1 (NS1) is a secreted glycoprotein critically involved in viral replication and pathogenesis.

Approximately 50-60% of the population acquires the Polyomavirus JC (JCV) during childhood, resulting in an asymptomatic, lifelong latent infection characterized by persistent anamnestic IgG antibodies.

The swine industry faces persistent challenges from highly contagious viral diseases that threaten animal health, food security, and global trade.

In modern poultry health management, serological testing plays a central role in monitoring immune status, evaluating vaccination programs, and detecting field exposure to pathogens.

Nanobodies, also known as variable heavy chain (VHH) antibodies, represent the smallest fully functional antigen-binding fragments.

The ferret (Mustela putorius furo) has become an essential model for modern biomedical research, especially in the field of respiratory disease.

The CRISPR/Cas9 system has revolutionized genome engineering by enabling precise, efficient, and programmable modification of DNA sequences in living cells.

In mRNA therapeutics production, inorganic pyrophosphatase (PPase) hydrolyzes inhibitory pyrophosphate (PPi) - a byproduct of in vitro transcription.